Tissue-Specific Modulation of Spexin Expression in Diet-Induced Obese Male Rats: Comparative Effects of Aerobic Exercise and Metformin
Authors:
- İsa AydemirIAİsa Aydemir
- Vedat ÇınarVÇVedat Çınar
- Taner AkbulutTaner Akbulut
- Mehmet Hanifi YalçınMYMehmet Hanifi Yalçın
- Yavuz YasulYYYavuz Yasul
- Berrin Tarakçi GençerBGBerrin Tarakçi Gençer
- Süleyman AydınSASüleyman Aydın
- Halil İbrahim CeylanHalil İbrahim Ceylan
- Nicola Luigi BragazziNicola Luigi Bragazzi
Open Access
- 10 August 2025
- journal article
- research article
- Published by MDPI AG in Applied Sciences
- Vol. 15 (16) , 8828
Abstract
Obesity, a major global health concern, is associated with systemic metabolic dysregulation. Spexin, a peptide implicated in appetite control and energy balance, may represent a biomarker and therapeutic target in obesity management. This study aimed to investigate tissue-specific modulation of spexin expression in obese male rats subjected to aerobic exercise and/or metformin treatment. Thirty-six Sprague–Dawley rats were randomly assigned to six groups (n = 6 per group): (i) control, (ii) obese control, (iii) exercise, (iv) metformin, (v) metformin + exercise, and (vi) a decapitation baseline group. Obesity was induced via a 12-week high-calorie diet. Subsequently, interventions were applied over 4 weeks: treadmill running (30 min/day, 5 days/week) and/or metformin (150 mg/kg/day). Post-intervention, body weight significantly decreased in intervention groups (p < 0.001) exercise (−13.7%), metformin (−14.6%), and metformin + exercise (−21.1%) compared to the obese control group. ELISA revealed tissue-specific effects on spexin expression. In skeletal muscle, spexin levels were highest in controls (628 ± 160.5 pg/mL), with a significant reduction in the metformin + exercise group (349 ± 84.7 pg/mL; p = 0.003, Cohen’s d = 2.17). In the liver, the control group showed the highest expression (443 ± 240.8 pg/mL), while metformin + exercise yielded the lowest (254 ± 20.4 pg/mL). In contrast, heart tissue maintained elevated spexin levels across all intervention groups, with the metformin + exercise group nearly matching control levels (617 ± 25.2 vs. 618 ± 53.2 pg/mL). Immunohistochemistry confirmed these patterns, with the highest cardiac histoscore in the metformin + exercise group (2.34 ± 0.09). Hierarchical clustering underscored distinct tissue-specific expression patterns, separating muscle from liver and heart. Collectively, these findings suggest that spexin is differentially regulated by exercise and metformin, with joint effects and complex, tissue-specific modulation. This highlights spexin’s potential as a biomarker and therapeutic target in precision obesity interventions.Keywords
This publication has 51 references indexed in Scilit:
- Aerobic Exercise and Weight Loss in AdultsJAMA Network Open, 2024
- Update on the Obesity Epidemic: After the Sudden Rise, Is the Upward Trajectory Beginning to Flatten?Current Obesity Reports, 2023
- Spexin status in relation to obesity and its related comorbidities: a systematic reviewJournal of Diabetes & Metabolic Disorders, 2020
- Metformin: Mechanisms in Human Obesity and Weight LossCurrent Obesity Reports, 2019
- Body Weight Considerations in the Management of Type 2 DiabetesAdvances in Therapy, 2018
- The mechanisms of action of metforminDiabetologia, 2017
- Effects of Metformin and Exercise Training, Alone or in Combination, on Cardiac Function in Individuals with Insulin ResistanceCardiology and Therapy, 2016
- Spexin is a novel human peptide that reduces adipocyte uptake of long chain fatty acids and causes weight loss in rodents with diet‐induced obesityObesity, 2014
- Energy Metabolism in the LiverComprehensive Physiology, 2014
- Dose-Independent Pharmacokinetics of Metformin in Rats: Hepatic and Gastrointestinal First-Pass EffectsJournal of Pharmaceutical Sciences, 2006